Clinical trial NCT03952117: Transcranial Direct Current Stimulation of the Motor Cortex in Essential Tremor
Official title: Transcranial Direct Current Stimulation of the Motor Cortex in Essential Tremor : A Randomized Controlled Pilot Study
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Essential Tremor
Transcranial Direct Current Stimulation
Keywords: primary motor cortex
Lead sponsor: Lebanese American University
Sponsor class: OTHER
First posted: 2019-05-16
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: TREATMENT

Brief summary: The current research is aimed at using Transcranial Direct Current Stimulation (tDCS) as complementary therapeutic tool in the treatment of essential tremor. Patients will be randomized into two groups (tDCS-cathode vs. tDCS-sham) according to detailed protocol. Main outcome will be measured by the change in tremor amplitude using an accelerometer pre and post cathodal tDCS of the motor cortex.

A total of 40 patients ought to be enrolled as specified in methodology. Secondary outcomes will assess TRG essential tremor rating assessment scale (TETRAS) as well as clinical monitoring.

Detailed description: Essential tremor (ET) is a common progressive neurological disorder and is the most common movement disorder. Worldwide , up to 5% of the population suffer from this disorder with an increased incidence with advanced age.

The proposed mechanism that underlies ET, the central oscillating network, is mainly composed of the olivocerebellar system, thalamus and motor cortex. An interruption in this circuit limits the ability of the cortex to reorganize and restore ET. a case of 76 year old female with essential tremor that disappeared following a cortico-subcortical prerolandic stroke despite complete motor recovery highlights the role of the motor cortex in the production and possible therapeutic role of the transcranial direct current stimulation.

Study design A randomized, sham-controlled, double blind and crossover study.

Study procedure:

The first visit is an inclusion visit Prior to starting the first tDCS session, the patient will be asked to fill his/her first TRG essential tremor assessment (TETRAS) scale. The physician will then quantitatively analyze the tremor on the most affected side using an accelerometer. Cathodal tDCS will be administered on the area representing the primary motor cortex and the anode over the contralateral supraorbital area. tDCS stimulation (cathodal and sham) will be done daily for 5 consecutive days during weeks 1 and 5. Each stimulation session will last 30 minutes. tDCS will be performed while the patient is at rest, without any concurrent cognitive or motor task.The two tDCS sessions will be separated by a 23 day washout period.

Patient will be asked to fill out their TETRAS at days 1 and 5 of each tDCS session (cathodal and sham), and days 12 and 19 after each tDCS session (cathodal and sham).

Accelerometer assessment of the tremor will be performed at days 1 and 5 of each tDCS stimulation session (cathodal and sham).

Eligibility criteria: Inclusion Criteria:

- Patients who fulfil the 2017 Movement society concusses statement criteria for essential tremor

Exclusion Criteria:

* Isolated focal tremor (voice, head)
* Orthostatic tremor with a frequency of more than 12 Hz
* Task and position specific tremor
* Sudden onset and stepwise deterioration of tremor
* History of substance abuse or dependence in the past
* Co-morbid medical conditions capable of producing or enhancing tremors
* Use of a medication with potential effect on tremor
* History of neurological disorders, brain tumors, brain surgery or abnormal neurological examination
* Epileptic disorders
* Cardiac pacemakers
* Metallic hardware in the head or scalp (surgical clips)
* Eczema or skin abrasion at the intended site of stimulation
* Currently pregnant or plan for pregnancy in the next 6 months
* Patients with prior experience with tDCS
* Major psychosocial problems or medical problems rendering informed consent impossible

Primary outcomes:
measure: Tremor amplitude
timeFrame: 5 days
Secondary outcomes:
measure: Functional impact of tremor
timeFrame: 19 days
Other outcomes:
Locations:
city: Beirut
country: Lebanon
facility: LAUMCRH
Study officials:
affiliation: Lebanese American University Medical Center
name: Rechdi Ahdab
role: PRINCIPAL_INVESTIGATOR
References: